
201 - 500 employees
Founded 1998
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
Biotechnology • Pharmaceuticals
Zealand Pharma is an international biotechnology company headquartered in Denmark with operations in Boston, USA, focused on the discovery, design, and development of innovative peptide-based and small-molecule medicines to improve metabolic health and extend human healthspan. The company develops therapies across obesity, congenital hyperinsulinism, short bowel syndrome, and chronic inflammatory diseases, and advances a pipeline that includes long-acting amylin, GLP, GIP, and GLP-2 analogs as well as Kv1. 3 ion channel blockers. Zealand Pharma is publicly listed on Nasdaq Copenhagen and emphasizes partnering, clinical development, and commercialization of peptide therapeutics.
🕒 May 7
Associate Director managing third-party vendor logistics for external engagements. Leading strategy and governance in the biotech sector at Zealand Pharma.
🇺🇸 United States – Remote
💵 $190k - $240k / year
🔥 Funding within the last year
💰 $4.1M Post-IPO Equity - Zealand Pharma on 2025-06
⏰ Full Time
🟠 Senior
👔 Director